The ASAM Patient Safety in Addiction Medicine Course (1 CME)
- Non-Member - $39
- Regular Member - Free!
- Retired - Free!
- Early Career Physician - Free!
- Resident - Free!
- Student - Free!
- Associate - Free!
- ASAM Staff - Free!
- International Member - Free!
- Emeritus Member - Free!
- Provisional Member - Free!
- Fellow Member - Free!
- Honorary Member - Free!
- CRT Member - Free!
Patient Safety in Addiction Medicine Course
Welcome to ASAM's Patient Safety in Addiction Medicine Online Course designed to prepare clinicians specializing in addiction medicine to promote patient safety in their practice using safety practices and systems-thinking approaches. In this course, clinicians will learn strategies to prevent errors, learn from errors that do occur, and learn how to take initiative in building a culture of safety in addiction medicine.
By taking this one-hour course, participants may satisfy primary board MOC requirements and what was a requirement for ABPM Diplomates.
This course is fully online and can be completed at your own pace. The flow of this online course uses a mix of didactic materials, case studies, learning activities, and assessments to help you understand patient safety in addiction medicine.
Begin the course by reviewing the Getting Started page that contains information about the structure and sequence of the course. From there, you can review the course introduction, faculty information, content modules, and different sections of the course to get acquainted with course navigation.
Dr. Anika Alvanzo, MD, MS, DFASAM
Dr. Anika Alvanzo is an Assistant Professor at Johns Hopkins University School of Medicine. Dr. Alvanzo graduated from George Washington University School of Medicine and Health Sciences and holds a master’s degree in biostatistics from Virginia Commonwealth University. She is a Diplomate of the American Board of Addiction Medicine, a Distinguished Fellow of the American Society of Addiction Medicine (ASAM), Region V Director for the ASAM Board of Directors and Immediate Past President of the Maryland-DC Society of Addiction Medicine.
At Johns Hopkins, Dr. Alvanzo is the Associate Medical Director at Addiction Treatment Services and the Center for Addiction and Pregnancy where she oversees medical care of patients in two comprehensive, outpatient substance use disorder treatment (SUD) programs. From 2011 – 2018, Dr. Alvanzo directed the Substance Use Disorders Consultation Service, a multidisciplinary addiction consultation service providing clinical consultation, brief intervention and treatment linkage services for inpatients with SUDs. Dr. Alvanzo directs the Addiction Medicine Rotation for the Johns Hopkins Urban Health Medicine-Pediatrics and Primary Care Internal Medicine Residency tracks. She has served as an expert on National Institutes of Health (NIH) and Substance Abuse and Mental Health Services Administration (SAMHSA) panels on the role of opioids in chronic pain and integration of recovery-oriented care in hospital and medical settings, respectively, and was both an invited rapporteur and panelist at the National Academies of Sciences, Engineering and Medicine, “Workshop on Integrating Infectious Disease Considerations with Response to the Opioid Epidemic”. Dr. Alvanzo’s research has focused on the association between trauma and substance use as well as sex and race/ethnicity disparities in risks for substance use disorders (SUD) and receipt of treatment-related services.
Dr. Melinda M. Campopiano von Klimo, MD (Consultant)
Dr. Melinda Campopiano has 20 years of experience in primary care medicine and addiction medicine including delivering care in hospitals, nursing homes, her own private practice, FQHC look-alikes, and for incarcerated patients. She has trained student health professionals, residents and health professionals in primary care, obstetrics, behavioral health, integration of care and addiction treatment including the use of pharmacotherapy for opioid and alcohol use disorders, syringe services and overdose prevention. She helped develop, implement, and evaluate an SBIRT curriculum for student health professionals in cooperation with the Pennsylvania Department of Health. As Senior Medical Advisor for SAMHSA, she developed seminal federal documents on opioid overdose prevention, pharmacotherapy for opioid use disorder, and substance-exposed pregnancy. She convened or chaired meetings on addiction and behavioral health involving stakeholders from across federal government (HHS, DOJ, ONDCP), research, clinical practice, and people with experience and oversaw regulation development and enforcement. Her current work at JBS includes providing medical and technical expertise to support RCORP and contributing to the evaluation design and implementation for HRSA’s MCHB. Dr. Campopiano received her medical degree from the University of Pittsburgh School of Medicine and completed her medical residency at University of Pittsburgh Medical Center’s Shadyside Family Practice. She is board certified in both Family Medicine and Addiction Medicine.
Dr. Miriam Komaromy, MD, FACP, DFASAM
Dr. Miriam Komaromy is the Medical Director of the Grayken Center for Addiction at the Boston Medical Center. Komaromy is one of the nation’s leading clinical educators for addiction medicine. She is board certified in Internal Medicine and Addiction Medicine. She has been an Associate Director in the ECHO Institute, leading ECHO programs that are focused on treatment of substance use disorders for the past 13 years. She consults with programs around the world on implementation of the ECHO model to expand access to specialized medical care, and particularly focuses on ECHO for addictions, mental health, care of complex populations, and ECHO programs to support community health workers. Dr. Komaromy provides clinical consultation and outpatient care for patients with complex substance use disorders. Dr. Komaromy is a member of the board of directors of the American Society of Addiction Medicine (ASAM), which is the largest addiction-specialty society in the United States. She is vice-chair of ASAM’s national medical education committee, and she chairs their Fundamentals of addiction medicine committee.
Dr. Michael Weaver, MD, DFASAM
Dr. Michael Weaver is a Professor in the Department of Psychiatry and Medical Director of the Center for Neurobehavioral Research on Addictions (CNRA) at the McGovern Medical School at the University of Texas Health Science Center at Houston (UTHealth). He received his M.D. degree from Northeast Ohio Medical University, and completed Residency in Internal Medicine and a
Clinical Research Fellowship in Addiction Medicine at Virginia Commonwealth University (VCU) Health System, and he is Board-certified in Internal Medicine through the American Board of Internal Medicine and certified in Addiction Medicine through the American Board of Preventive Medicine. Dr. Weaver is the Sub-Board Chair for Addiction Medicine on the American Board of Preventive Medicine, and also serves as the Chair of the Examination Committee for certification in Addiction Medicine. He has been a member of ASAM for over 20 years and currently serves as a member of the Publications Council and the Annual Conference Program Planning Committee. He is currently involved in patient care, medical education, and research. Dr. Weaver sees patients in the Innovations Addiction Treatment Clinic at the Texas Medical Center in Houston. He has extensive experience teaching about addiction to medical students, residents, and community professionals at all levels. He has been involved in multiple research projects, and currently is collaborating with other researchers in the CNRA on studies involving cocaine, methamphetamine, marijuana, and electronic cigarettes. Dr. Weaver has multiple publications in the field of addiction medicine, including the book "Addiction Treatment" published by Carlat Publishing in 2017.
Dr. Mark A. Weiner, MD, DFASAM
Dr. Mark Weiner received his undergraduate degree (B.S. Psychology) at the University of Michigan, Ann Arbor. He earned his medical degree at Cornell University Medical College in New York City. He completed his internship and residency in Internal Medicine at Northwestern University – McGaw Medical Campus in Chicago, Illinois. He is board certified in Internal Medicine and Addiction Medicine. Dr. Weiner is located in Ann Arbor, Michigan practicing full time inpatient and outpatient Addiction Medicine. He is the Section Chief of Addiction Medicine and the Medical Director of Substance Use Disorders as well as the Program Director for the Addiction Medicine Fellowship at St Joseph Mercy Hospital, Ann Arbor. Additionally he serves as Medical Director of IHA Recovery Medicine.
He has participated in planning the ASAM preconference, Common Threads: Pain and Addiction, since 2011 and is the current chair. He also is a member of the ASAM Annual Meeting planning committee since 2014 and is an editor of the ASAM Pain and Addiction Handbook. In 2020, Dr. Weiner began serving as the chair of ASAM Maintenance of Certification for the ASAM Medical Education Committee. He also is a member of the ASAM Annual Meeting planning committee since 2014 and is an editor of the ASAM Pain and Addiction Handbook.
|Access Date||Quiz Result||Score||Actions|
Credits and Disclosures
Patient Safety in Addiction Medicine Course
Enduring: 4/30/2020 – 4/30/2023
Faculty Disclosure Information
• Anika A. H. Alvanzo, MD, MS, DFASAM - Indivior, Consulting Fees, Consulting
• Melinda Campopiano, MD - No Financial Disclosures, ASAM Consultant for Patient Safety in Addiction Medicine Course
Planning Committee Disclosure Information
• Miriam S. Komaromy, MD, FACP, DFASAM - No Financial Disclosures
• Michael Weaver, MD, DFASAM - No Financial Disclosures
• Mark A. Weiner, MD, DFASAM - No Financial Disclosures
ASAM CME Committee Reviewer
Herbert L. Malinoff, MD, FACP, DFASAM - No disclosures
ACCME Accreditation Statement:
The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA Credit Designation Statement:
The American Society of Addiction Medicine designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABPM Maintenance of Certification (MOC)
Successful completion of this activity can be used to satisfy the American Board of Preventive Medicine (ABPM) CME requirement for Maintenance of Certification program.
ABA Maintenance of Certification (MOC)
This activity contributes to the CME component of the American Board of Anesthesiology’s redesigned Maintenance of Certification in Anesthesiology TM (MOCA®) program, known as MOCA 2.0®.
ABP Maintenance of Certification (MOC)
Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn a maximum of 1 MOC point in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.
ABPath Continuing Certification Program
Pathologists under CC (formerly MOC) can earn up to maximum of 1 AMA PRA Category 1 Credit(s)TM in the American Board of Pathology’s (ABPath) Maintenance of Certification program.
ABIM Maintenance of Certification (MOC)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1 Medical Knowledge and Patient Safety MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
ABAM Transitional Maintenance of Certification (Tmoc)
Successful completion of this activity can be used to satisfy the American Board of Addiction Medicine (ABAM) for Tmoc as credits towards ABAM LLSA Part II requirements.
The American Board of Psychiatry and Neurology (ABPN)
Successful completion of this CME activity can be used to satisfy the American Board of Psychiatry and Neurology’s (ABPN) CME requirement for Maintenance of Certification program.
Continuing Education Credits (CEUs)
Non-physician participants will receive a certificate of attendance upon completion of the activity and an online evaluation confirming their participation. Participants should submit his/her certificate of attendance to their professional organization/institute.
Program Planning Committee, CME Committee, Medical Education Council (MEC), and Faculty Disclosure Information
In accordance with disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME activities. These policies include resolving all possible conflicts of interest for the Planning Committees, CME Committee, MEC, and Faculty. All activity Planning Committee members and Faculty have disclosed relevant financial relationship information. The ASAM CME Committee has reviewed these disclosures and determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity.